Author Question: When would a researcher want to implement a factorial design? A) When he/she wants to study the ... (Read 37 times)

panfilo

  • Hero Member
  • *****
  • Posts: 572
When would a researcher want to implement a factorial design?
 
  A) When he/she wants to study the effect of a single independent variable
  B) When he/she wants to study the effect of a single dependent variable
  C) When he/she wants to study the effects of multiple independent variables
  D) When he/she wants to study the effects of multiple dependent variables

Question 2

The results of the Orne and Evans (1965) study suggested that ___________ does not affect subjects' willingness to carry out various dangerous tasks.
 
  a. hypnosis
  b. food deprivation
  c. alcohol intoxication
  d. sleep deprivation



EAN94

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

C

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library